Resonance Health Ltd (AU:RHT) has released an update.
Resonance Health Ltd has recently received a substantial R&D Tax Incentive payment of $818,706 from the Australian Tax Office for their FY2023 research activities. This financial boost is a result of the Australian Government’s R&D Tax Incentive Program and contributes to the company’s cash reserves, details of which will be disclosed in their upcoming Quarterly Activities Report. Resonance Health is recognized for its high-quality medical device software and services, used worldwide by clinicians and in clinical trials.
For further insights into AU:RHT stock, check out TipRanks’ Stock Analysis page.
